Items Tagged ‘DNA sequence’

March 29, 2013

A Setback on the Road to a Parkinson’s Cure

By Logan Lafferty Logan Lafferty

One of the most promising treatments for Parkinson’s disease has hit a snag after researchers found evidence that it may make patients worse…The NorthShore study examined 1,098 Parkinson’s patients who had their DNA sequenced at the Mayo Clinic and were then contacted up to 15 years later. Those with a genetic variant that led to […]

View full entry

Tags: alpha synuclein, Bloomberg Businessweek, DNA sequence, genetic variant, NorthShore, parkinson's disease, setback


March 21, 2013

Parkinson’s Patients May Be Harmed by Novel Treatment

By Logan Lafferty Logan Lafferty

The study examined the progression of 1,098 patients who had their DNA sequenced at the Mayo Clinic and were contacted as many as 15 years later to determine how they were faring…Alnylam, based in Cambridge, Massachusetts, licensed alpha- synuclein technology from the Mayo Clinic and is developing a product that would be delivered directly into […]

View full entry

Tags: Alnylam, Bloomberg Businessweek, DNA sequence, new technology, parkinson's disease


February 15, 2013

Medicine for the Rich Is About to Get Cheap Enough for Regular People

By Logan Lafferty Logan Lafferty

After years of exotic and very expensive machines sequencing DNA, the genomics industry finally looks poised for its cell phone moment…“Today, most companies have a specific niche. The full integrated package is being promised but is not really being offered,” says Dr. Gianrico Farrugia, the director of the Mayo Clinic Center for Individualized Medicine. With […]

View full entry

Tags: Center for Individualized Medicine, DNA sequence, Dr. Gianrico Farrugia, genomics industry, Wired


Contact Us · Privacy Policy